News
Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren't completely sure why. They may have a better idea now, ...
Researchers have used spatial Deep Visual Proteomics workflow to reveal why some patients with the hereditary disease remain ...
The Asia Pacific enzymes market is set to experience robust growth, with an anticipated annual growth rate of 7.8% over the forecast period. This growth is fueled by increasing industrialization, ...
Introduction: The Global Enzymes Market is poised for significant growth over the coming decade, with projections indicating a substantial increase to $19,249.4 million by 2031. This growth, estimated ...
A new enzyme can turn lignin waste into valuable chemicals using green, hydrogen peroxide-based processing, offering a cleaner, sustainable alternative to petroleum-based methods. Approximately 98% of ...
Xencor's stock drops 65%, hitting all-time lows. Focus shifts to autoimmune research, but no near-term catalysts. Read why ...
“Our vision at Quantumzyme is to help reshape the future of industrial chemistry through the power of enzymatic catalysis,” stated Naveen Kulkarni, CEO of Quantumzyme. “By combining AI and ...
Observing reactions in this manner helps scientists understand how catalysts work. These new insights could potentially lead ...
One of the most significant challenges facing current nanozyme technologies is the lack of well-defined active sites, which ...
“Our results show that enzymes are not just chemical catalysts, but also mechanical objects finely tuned by evolution. It’s a new way of thinking about life—as a programmable physical system,” ...
Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results